Diabetes, a world public health concern
Ingredia launched Pep2Dia®, specifically developed to help manage blood sugar level. This patented milk protein hydrolysate has an active dipeptide AP, which inhibits the alpha glucosidase. Preclinical and clinical studies have proven the efficacy of Pep2Dia® to reduce glycaemia after a meal.
Today more than 350 million people live with high blood sugar glucose (1). In 5 to 10 years, if nothing is done, the people with prediabetes, who have a higher-than-normal glycaemia in the morning fasting, will become diabetic. Everywhere, diabetes is on the rise and affects 8.5% of the adult population (2).
Diabetes leads to adverse effects on health, and in the long run can affect eyes, kidneys, feet, and cause heart conditions or stroke. This chronic disease is one of the causes of premature mortality but type 2 diabetes can be avoided because prediabetes is reversible!
Pep2Dia®, an innovative bioactive to delay the onset of type 2 diabetes, regulates blood sugar levels after meals.
Pep2Dia® is a patented (3) milk protein hydrolysate with an active dipeptide AP, specifically designed for prediabetes, to help manage blood sugar. AP peptide acts as an inhibitor of the alpha glucosidase. This digestive enzyme hydrolyses polysaccharides into glucose and allows absorption. Its inhibition lowers blood sugar levels.
Pep2Dia® is the result of extensive research and collaboration between Ingredia’s scientists and LIENSs-CNRS La Rochelle University in France.
Pep2Dia® has proven efficacy on glycaemia after meals.
Pre-clinical and clinical studies support Pep2Dia®’s action to reduce postprandial glycaemia with a significative effect versus the placebo.
To prevent Type 2 diabetes change your food habits, exercise and take … Pep2Dia®!
References:
1) International Diabetes Fundation, Atlas 2018
2) WHO Global report on diabetes, 2016
3) Patent n° WO 2015/124867
Click here for more information
Related News
-
News Accepting novel excipients for innovative drug development
With the rapid development and manufacturing of new drugs and therapeutics being pushed through the pipeline, excipient manufacturers are navigating a challenging landscape to meet the demand for new and novel excipients. -
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News Connect to Frankfurt - Five reasons to tune in
Get a jump-start on your CPHI Frankfurt experience with exclusive access to our online event platform. -
News WHO calls on public for ideas to rename monkeypox
‘Poxy McPoxface’, ‘TRUMP-22’, and ‘Mpox’ are just some of the suggestions submitted by the public -
News Chinese market represents ‘single greatest generational opportunity’ for Pharma
China’s pharmaceutical industry is changing from formerly generics-focused into one that emphasizes innovation, spurred by shifting government policy and an aging population. -
News Monkeypox Update: Vaccine shortage, sewage surveillance and global testing
As concern over the monkeypox outbreak continues to rise, we take a look at major developments from the first week of August. -
News mRNA production partnership to scale-up COVID-19 vaccine development
GreenLight Biosciences and Samsung Biologics announce mRNA production partnership to scale mRNA vaccine production to a commercial level with Samsung's expanded mRNA drug substance manufacturing site. -
News The Data Revolution: How Real-World Evidence is Changing Pharma
A look at the companies extracting valuable insights from health data to accelerate clinical development and support regulatory decision making.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance